Skip to main content
Download PDF

Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

Stem Cell Research & Therapy volume 15, Article number: 110 (2024) Cite this article

The Original Article was published on 18 March 2021

Retraction Note: Stem Cell Research & Therapy (2021) 12:192

https://doi.org/10.1186/s13287-021-02265-1

The Editors-in-Chief have retracted this article. An investigation by the Publisher has found a number of articles, including this one, which share similar concerns, involving but not limited to, irregularities with respect to submission and authorship. The Editors-in-Chief therefore no longer have confidence in the results and conclusions presented in this article. Alexander Markov, Lakshmi Thangavelu, and Ali Hassanzadeh do not agree to this retraction. Surendar Aravindhan, Angelina Olegovna Zekiy, Mostafa Jarahian, Max Stanley Chartrand, Yashwant Pathak, Faroogh Marofi and Somayeh Shamlou did not respond to correspondence from the Editor about this retraction.

Author information

Authors and Affiliations

  1. Tyumen State Medical University, Tyumen, Russian Federation

    Alexander Markov

  2. Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India

    Lakshmi Thangavelu

  3. Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, India

    Surendar Aravindhan

  4. Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russia

    Angelina Olegovna Zekiy

  5. German Cancer Research Center, Toxicology and Chemotherapy Unit (G401), 69120, Heidelberg, Germany

    Mostafa Jarahian

  6. DigiCare Behavioral Research, Casa Grande, AZ, USA

    Max Stanley Chartrand

  7. Professor and Associate Dean for Faculty Affairs, Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA

    Yashwant Pathak

  8. Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

    Faroogh Marofi

  9. Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Somayeh Shamlou & Ali Hassanzadeh

  10. Cell Therapy and Regenerative Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Ali Hassanzadeh

  11. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Ali Hassanzadeh

Authors
  1. Alexander Markov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lakshmi Thangavelu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Surendar Aravindhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angelina Olegovna Zekiy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mostafa Jarahian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Max Stanley Chartrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yashwant Pathak
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Faroogh Marofi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Somayeh Shamlou
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ali Hassanzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Hassanzadeh.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s13287-021-02265-1.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markov, A., Thangavelu, L., Aravindhan, S. et al. Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 15, 110 (2024). https://doi.org/10.1186/s13287-024-03733-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13287-024-03733-0

Stem Cell Research & Therapy

ISSN: 1757-6512